While SSRIs are FDA-approved to manage obsessive-compulsive disorder (OCD), panic disorder (PD), post-traumatic stress disorder (PTSD), and social anxiety disorder (SAD), they are not FDA-approved for ASD-related mood changes or behavioral changes
Tracking progress through measurable data such as body composition scans, performance metrics, and blood work provides a more reliable picture of results than visual appearance alone
ADA Guidelines on Cardiometabolic Risk The ADA Standards of Care recommend semaglutide for people with type 2 diabetes who are at high risk for heart disease
Delfan, N., H
The approval makes the UK the first country to authorise an oral version of a GLP-1 weight loss treatment, a drug class already widely used in injectable form
Although GI side effects associated with the use of oral semaglutide are limited, they may prompt some patients to discontinue the medication, with consequent rapid resolution of GI effects